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Electrophysiological changesAbstract Introduction: Children with juvenile connective tissue diseases (JCTDs) may have a wide
variety of clinical features ranging from fever or a simple arthritis to complex multisystem autoim-
mune diseases.
Aim of the work: To study clinical and electrophysiological peripheral and central neuromuscu-
lar changes in children with connective tissue diseases.
Patients and methods: Thirty children with different JCTDs were enrolled. Clinical and neuro-
logical examination and laboratory investigations were done. Electrophysiological evaluation was
performed and included: peripheral nerve conduction studies, late responses, somatosensory evoked
potential and electromyography.
Results: Twenty patients had juvenile idiopathic arthritis (JIA) (66.7%), 8 patients had juvenile
systemic lupus erythematosus (JSLE) (26.7%), one patient had juvenile systemic sclerosis (JSScl),
and one patient had juvenile overlap syndrome (JSScl and polymyositis). Clinical neurologic abnor-
malities were present in 3 patients (ulnar neuropathy, median neuropathy and polymyositis). Elec-
trophysiological abnormalities were detected in 18 patients (clinical in 3 and subclinical in 15
patients) and included ulnar entrapment neuropathy, median axonal neuropathy, demyelinating
sensory motor polyneuropathy, deep peroneal nerve entrapment at the ankle (anterior tarsal tunnel
syndrome), prolonged posterior tibial somatosensory evoked potential latency and prolonged H
reflex latency not explained by peripheral neuropathy, increased H/M ratio and myopathic motor
units. The most common electrophysiological abnormalities were present in patients with JSLE.
234 H. El-Moghazi Sultan et al.Conclusion: Clinical neurological abnormalities are not common in JCTDs whereas subclinical
neurological abnormalities are common findings. Juvenile systemic lupus erythematosus had the
most common abnormalities among JCTDs. Polyneuropathy in JIA is commonly of demyelinating
type. Entrapment neuropathy is less frequent than in adults.
 2015 The Authors. Publishing services provided by Elsevier B.V. on behalf of Egyptian Society of
Rheumatic Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Children with juvenile connective tissue diseases (JCTDs)
may have a wide variety of clinical features ranging from fever
or a simple arthritis to complex multisystem autoimmune
diseases [1]. Juvenile connective tissue diseases (JCTDs) are
autoimmune multisystem inflammatory disorders including
juvenile idiopathic arthritis (JIA), juvenile systemic lupus
erythematosus (JSLE), juvenile systemic sclerosis (JSScl),
juvenile dermatomyositis (JDM) and polymyositis, juvenile
mixed connective tissue disease (JMCTD), juvenile Sjo¨gren’s
syndrome (JSS) and vasculitis [2]. Different organs other
than the musculoskeletal system may be involved including
skin, kidneys, cardiopulmonary system, gastrointestinal and
nervous systems [3].
Neurologic manifestations of rheumatic disorders can arise
in both primary and secondary fashion [4]. That is, the anti-
bodies or cellular immune elements responsible for the under-
lying disease can directly attack and injure nerves, muscle,
brain, spinal cord, and sensory organs. On the other hand,
innocent bystander effects of such rheumatic disease accompa-
niments as the hypercoagulable state, inflammation of the
blood vessel wall, immune complex deposition and side effects
of medications used in the treatment of rheumatic disease also
take their toll on the nervous system [5]. Electrophysiological
studies including nerve conduction studies (NCSs), elec-
tromyography (EMG) and somatosensory evoked potentials
(SEPs) are most often used to diagnose disorders of the
peripheral nervous systems (PNS) and central nervous systems
(CNS) and provide valuable information about the underlying
pathology [6,7].
The aim of this study was to study the clinical and
electrophysiological peripheral and central neuromuscular
changes in children with connective tissue diseases (CTDs)
and to describe the neurologic complications of childhood
rheumatic disease.
2. Patients and methods
Thirty children with different JCTDs (JIA, JSLE, JSScl, JDM
and polymyositis, juvenile overlap syndrome and JSS)
attending the pediatric rheumatology outpatient in Al-Shatby
children university hospital were enrolled. Exclusion criteria
included the presence of other neurological diseases, endocr-
inal, chronic infection, malignancy and heritable connective
tissue diseases. Clinical and neurological examination and
laboratory investigations were done. Thirty healthy children
of matched age and sex were included as a control group.
The study was approved by the local ethics committee of the
Faculty of Medicine, Alexandria University and the patients
gave an informed consent before inclusion in the study.Electrophysiological evaluation was performed and
included:
1. Peripheral NCSs: Nerve conduction studies were carried
out using NIHON KOHDEN (Neuropack 2) electrophysi-
ologic apparatus. All recordings of action potentials were
carried out by surface electrodes (8 mm) in diameter and
a ground electrode was placed between the stimulating
and recording electrodes. Stimulation was carried out using
bipolar stimulator having a production current ability of
50 mA. The filter setting was between 2 Hz and 10 kHz.
The following nerves were studied unilaterally; sural nerve
(sensory study), posterior tibial and deep peroneal nerves
(motor study), radial nerve (sensory study), median and
ulnar nerves (motor and sensory studies). Involvement of
one peripheral nerve only was defined as mononeuropathy.
Abnormality in 2 or more nerves was defined as a periph-
eral neuropathy electrophysiologically [8].
2. Late responses: F wave of median and ulnar nerves and the
soleal H-reflex were performed unilaterally.
3. SEPs: SEPs of median and posterior tibial nerves with cor-
tical recording were done.
4. EMG: Standard concentric needle EMG of gluteus medius
and tibialis anterior was performed unilaterally.
Statistical analysis: Student t and Mann–Whitney tests were
used to determine statistical differences between patients and
controls as regards the values of NCSs and SEPs. Normal
values for our laboratory were obtained from control children
and abnormal values were defined as 2 standard deviations
above/below the normal mean. Significant values were consid-
ered at p< 0.05.3. Results
Twenty-two patients were girls (73.3%), and 8 patients
(26.7%) were boys. Their age ranged from 6 to 16 years with
a mean of 12.37 ± 2.92 years. There was no statistically signif-
icant difference between patients and controls as regards age
(p= 0.35) and sex (p= 0.27). Twenty children had JIA, 8
had JSLE, one had JSScl and another had juvenile overlap
syndrome.
Patients had involvement of various systems; 29 patients
(96%) had articular manifestations, and 22 (73%) developed
extra-articular extra-neurological manifestations during the
course of disease (skin manifestations, subcutaneous nodules,
fever, headaches, hypertension, diabetes mellitus, abdominal
pain and fatigue). Only 3 patients (10%) developed neurolog-
ical abnormalities; two of them had JSLE associated with
lupus nephritis (one with ulnar mononeuropathy who had
decreased sensation on ulnar nerve distribution of the right
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muscles, partial claw hand deformity and grade 2 weakness
of the hypothenar muscles, interossei and adductor pollicis
muscles; the other one with median mononeuropathy who
had decreased sensation on median nerve distribution of the
right hand associated with grade 3 weakness of the thenar
muscles. Phalen’s and Tinel’s tests were negative) and the
3rd had overlap syndrome (JSScl and JDM), showed bilateral
symmetrical proximal muscle weakness of the 4 limbs
associated with hardening of skin and subcutaneous calci-
nosis. All patients received non-steroidal anti-inflammatory
drugs (NSAIDs) and corticosteroids, 19 received methotrexate
(MTX), 6 received hydroxychloroquine (HCQ), 5 received
azathioprine (AZA), one received sulfasalazine (SAS), one
received mycophenolate mofetil (MMF) and another received
cyclophosphamide (CYC). Treatment was received at the
optimal doses according to weight and disease activity.
As regards laboratory findings, 15 patients (50%) showed
abnormal blood picture (anemia, leukocytosis, leucopenia,
thrombocytosis, thrombocytopenia), 14 patients (46%) had
increased acute phase reactants and 7 patients had proteinuria.
Creatine phosphokinase (CPK) level was normal in all studied
patients.
The results of motor conduction studies in patients and
controls are demonstrated in Table 1. Statistically significantTable 1 Motor nerve conduction studies of the median, ulnar, post
diseases children and control.
Median (range)
Mean ± SD
Motor NCSs
Latency (ms) Amplitud
Median nerve
Patients (n= 30) 3 (1.9–4.7) 11.5 (1.2–
3.04 ± 0.6 11.6 ± 4.
Control (n= 30) 3.4 (2.4–3.7) 10.5 (6.3–
3.2 ± 0.4 11.1 ± 3.
t 1.03 0.49
p 0.31 0.63
Ulnar nerve
Patients (n= 30) 2.7 (1.6–5) 8.9 (0.8–1
2.7 ± 0.6 8.8 ± 3.4
Control (n= 30) 2.4 (1.9–2.8) 11.5 (6.8–
2.4 ± 0.3 11.8 ± 2.
t 2.45 3.82
p 0.017 <0.001
Posterior tibial nerve
Patients (n= 30) 3.8 (2.4–6.5) 19 (5.5–32
3.9 ± 0.9 16.8 ± 7.
Control (n= 30) 3.3 (2.1–4.6) 15.3 (5–23
3.4 ± 0.6 15.1 ± 4.
t or Z 2.66 1.01
p 0.01 0.31
Deep peroneal nerve
Patients (n= 30) 4.1 (2.8–7) 2.7 (0.8–1
4.3 ± 0.97 3.5 ± 2.4
Control (n= 30) 3.8 (2.5–5.1) 3 (2–7)
3.8 ± 0.7 3.4 ± 1.3
t 2.25 0.62
p 0.028 0.54
NCSs: nerve conduction studies. Bold values are significant at p< 0.05.differences were detected between patients and controls as
regards the distal latency and conduction velocity of posterior
tibial and deep peroneal nerves as well as the ulnar nerve distal
latency and amplitude. The results of sensory conduction studies
in patients and controls are demonstrated in Table 2. Statistically
significant differences were found as regards the distal latency,
conduction velocity and amplitude of sural nerve as well as the
distal latency of the median and ulnar nerves.
A significant difference was found between patients and
controls as regards the H reflex latency (25.57 ± 3.39 vs
22.01 ± 3.25, p< 0.001). Significant differences were recog-
nized as regards posterior tibial SEP latency and amplitude
(Table 3).
Electromyographic abnormalities were detected in 10
patients (33%). One of them had abnormal resting potentials
in the form of complex repetitive discharge, small short
polyphasic motor units and early recruitment (consistent with
electrophysiologic findings of polymyositis). The other 9
patients had small short polyphasic motor units consistent
with myopathy with no abnormal resting activities, with
normal recruitment.
By comparing the values of electrophysiological studies
obtained from patients to the cut off values obtained from
controls, electrophysiological abnormalities were detected in
18 patients (clinical in 3, subclinical in 15).erior tibial and deep peroneal nerves in juvenile connective tissue
e (mV) NCV (m/s) F latency (ms)
23) 57 (39–79) 22.4 (16–27)
7 56.6 ± 9.1 22.4 ± 2.7
19) 52.5 (48–68) 23 (19.5–26)
9 53.7 ± 5.02 22.8 ± 1.7
1.55 0.66
0.13 0.51
7) 58.5 (42.5–92) 23 (16–27)
59.98 ± 13.4 23 ± 2.7
18) 60.8 (50–79) 22.8 (19–26.6)
7 61.9 ± 8.9 22.5 ± 2.1
0.65 0.79
0.52 0.43
) 46 (31–64)
3 46.98 ± 6.9
) 49.5 (45–62)
9 51.2 ± 5.1
2.69
0.009
2) 49 (39–67)
49.03 ± 6.3
51.3 (45–60)
52.2 ± 4.9
2.15
0.036
Table 2 Sensory nerve conduction studies of the median, ulnar, superficial radial and sural nerves in juvenile connective tissue
diseases children and control.
Median (range)
Mean ± SD
Sensory NCSs
Latency (ms) Amplitude (lV) NCV
Median nerve
Patients (n= 30) 2.95 (2–4) 30 (14–108) 52 (34.3–96)
2.97 ± 0.5 39.95 ± 26.7 54.5 ± 12.3
Control (n= 30) 2.4 (1.4–3.3) 46.5 (20.7–65) 50.5 (49–59)
2.44 ± 0.45 43.6 ± 15.6 52.3 ± 3.4
t or Z 4.23 1.81 0.97
p <0.001 0.07 0.34
Ulnar nerve
Patients (n= 30) 2.6 (1.8–3.8) 30 (0.5–108) 54 (31.3–80)
2.47 ± 0.6 37.6 ± 24.04 55.2 ± 10.5
Control (n= 30) 2.05 (1.6–2.5) 36.5 (22–45) 51.5 (49–64)
2.1 ± 0.3 35.97 ± 8.3 53.1 ± 4.5
t or Z 5.92 1.17 0.997
p <0.001 0.24 0.33
Superficial radial nerve
Patients (n= 30) 2.2 (1.7–3.4) 30 (10–71) 53.5 (37–87)
2.3 ± 0.4 32.6 ± 17.1 55.8 ± 11.7
Control (n= 30) 2.2 (1.7–3) 30 (16.8–45) 53.5 (49–55.6)
2.3 ± 0.4 31.22 ± 8.6 52.7 ± 2.2
t 0.85 0.52 1.43
p 0.4 0.6 0.16
Sural nerve
Patients (n= 30) 3.8 (2.2–5) 12.3 (3–90) 45 (33.3–60)
3.6 ± 0.7 16.1 ± 15.7 45.02 ± 6.3
Control (n= 30) 2.4 (1.7–3.3) 20.2 (10–32) 49 (44–55)
2.5 ± 0.5 21.2 ± 6.4 49.4 ± 4.1
t or Z 7.31 3.6 3.2
p <0.001 <0.001 0.002
NCSs: nerve conduction studies. Bold values are significant at p< 0.05.
Table 3 Somatosensory evoked potential of median and posterior tibial nerves in juvenile connective tissue diseases children and
control.
Median (range)
Mean ± SD
Patients (n= 30) Control (n= 30) t or Z p
Median nerve
SEP latency (ms) 17 (15–20) 17 (15.5–19) t= 0.43 0.67
16.98 ± 1.1 16.9 ± 0.8
SEP amplitude (lV) 7.65 (3–20) 3.56 (6.5–18) t= 0.1 0.92
8.8 ± 4.2 9.4 ± 3.5
Posterior tibial n
SEP latency (ms) 36.9 (30–43) 33.8 (30–37) t= 2.07 0.04
37 ± 3.5 34.8 ± 2.2
SEP amplitude (lV) 4 (1–14) 6 (3.8–13) Z= 3.33 0.001
5 ± 3.2 6.4 ± 2.2
SEP: somatosensory evoked potential. Bold values are significant at p< 0.05.
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logic abnormalities; seven out of 8 patients (87%) (2 clinical
and 5 subclinical). Subclinical electrophysiological abnormali-
ties in JSLE patients included demyelinating sensory polyneu-
ropathy in one patient, prolonged posterior tibial SEP latency
and prolonged H reflex latency (not explained by peripheral
neuropathy) in 2 patients, increased H/M ratio in one patientand myopathic motor unit without any other electrophysiolog-
ical abnormality in 2 patients.
Electrophysiologic abnormalities were detected in 10 out of
20 patients with JIA (50%). All had only subclinical findings in
the form of demyelinating sensory motor polyneuropathy in 2
patients, right deep peroneal nerve (DPN) entrapment at the
ankle (anterior tarsal tunnel syndrome) in one patient,
Table 4 Relationship between electrophysiological abnormal-
ities and the drug received by the studied children with juvenile
connective tissue diseases.
Medication n
(%)
Electrophysiological abnormalities v2 p
Normal
(n= 12)
Abnormal
(n= 18)
Prednisolone
No 0 (0) 0 (0)  –
Yes 12 (100) 18 (100)
NSAIDs
No 2 (16.7) 8 (44.4) 2.5 0.24
Yes 10 (83.3) 10 (55.6)
MTX
No 3 (25) 8 (44.4) 1.17 0.44
Yes 9 (75) 10 (55.6)
AZA
No 11 (91.7) 14 (77.8) 1 0.62
Yes 1 (8.3) 4 (22.2)
HCQ
No 11 (91.7) 13 (72.2) 1.7 0.36
Yes 1 (8.3) 5 (27.8)
SAS
No 12 (100) 17 (94.4) 0.69 1
Yes 0 (0) 1 (5.6)
MMF
No 12 (100) 17 (94.4) 0.69 1
Yes 0 (0) 1 (5.6)
CYC
No 12 (100) 17 (94.4) 0.69 1
Yes 0 (0) 1 (5.6)
NSAIDs: non-steroidal anti-inflammatory drugs; MTX: methotrexate;
AZA: azathioprine; HCQ: hydroxychloroquine; SAS: sulfasalazine;
MMF: mycophenolate mofetil; CYC: cyclophosphamide.
Peripheral and central neuromuscular changes in connective tissue 237prolonged posterior tibial SEP latency without peripheral neu-
ropathy in one patient and myopathic motor units without any
other electrophysiological abnormality in 6 patients.
One patient with overlap syndrome (JSScl and polymyosi-
tis), showed electrophysiological evidences of polymyositis
(complex repetitive discharge, myopathic motor units and
early recruitment). The patient with JSScl did not show any
electrophysiologic abnormalities.
No relationship was found between electrophysiological
abnormalities and different parameters (disease duration, gap
between disease onset and start of treatment and intake ofTable 5 Comparison between children with juvenile connective tissu
without as regards the disease duration and the gap between disease
Median (range)
Mean ± SD
Elect
Norm
Disease duration (month) 60 (3
57.8
Gap between disease onset and start of treatment (month) 12 (0
9.9 ±prednisolone, NSAIDs, MTX, HCQ, AZA, CYC, MMF and
SAS (Tables 4 and 5). In this work only one patient received
CYC, another one received MMF and a third one received
SAS. These 3 patients showed electrophysiological
abnormalities.
4. Discussion
Peripheral and central neurological complications in adult
patients with CTDs have been previously studied [9–11], but
for children are still deficient.
In the current study clinical and electrophysiological studies
were implemented to detect neurologic abnormalities in chil-
dren with JCTDs. Clinical neurological abnormalities were
present in 3 patients (10%), and subclinical neurologic abnor-
malities were present in 15 (50%). Both clinical and subclinical
neurologic abnormalities were present mainly in JSLE
patients. There were no clinical neuropathic abnormalities in
the JIA patients or in the patients with JSScl or overlap. This
finding is consistent with other studies which found that the
nervous system is commonly affected in children with JSLE,
and it was reported to occur in 22–95% [12] and is less preva-
lent in other JCTDs [13].
Patients with JSLE showed clinical neuropathic abnormal-
ities in 25% of patients and subclinical electrophysiologic
abnormalities in 62%. This finding is consistent with another
study on adult systemic lupus erythematosus (SLE) patients
that found clinical signs of peripheral neuropathy in 28%
and abnormal electrophysiological findings in 56%. This
clearly suggested that a sizable proportion of SLE patients
have subclinical peripheral nerve disease [8].
Peripheral NCS abnormalities in JSLE patients were in the
form of right ulnar entrapment mononeuropathy, right median
axonal mononeuropathy and demyelinating sensory polyneu-
ropathy. These results are of support to the findings of another
study on JSLE patients reporting that peripheral nerve
involvement is the most common presentation [14]. Peripheral
neuropathy in JSLE patients develops due to vasculitic insult
to vasa nervosum. There is Wallerian degeneration of nerve
fibers secondary to ischemic infarction due to occlusion of
blood vessels caused by leukocytoclastic vasculitis. In their
study, sural nerve biopsy in JSLE neuropathy patients found
that endoneurial immune complex deposition also plays an
important role in the demyelinating process and axonal dam-
age seen in peripheral neuropathy [14].
In 2 patients with JSLE, increased H-reflex latency was not
associated with peripheral neuropathy; this electrophysiologi-
cal finding is coincident with the study done for adult SLE
patients that found prolonged or absent H reflex as commone diseases and abnormal electrophysiological findings and those
onset and start of treatment.
rophysiological abnormalities Z p
al (n= 12) Abnormal (n= 18)
–96) 54 (12–102) 0.36 0.72
± 33.4 53.3 ± 30.4
–24) 8 (0–90) 0.15 0.88
8.6 17.67 ± 24.1
238 H. El-Moghazi Sultan et al.abnormal parameters. It was suggested that the proximal nerve
segment may be prominently involved and underlying patho-
physiological mechanism affecting the nerves does so in a patchy
manner rather than through a dying back phenomenon [8].
As regards JIA patients, electrophysiologic abnormalities
were detected in 50%. All had only subclinical findings, in the
form of demyelinating polyneuropathy in 10%, right DPN
entrapment at the ankle (anterior tarsal tunnel syndrome) in
5%, prolonged SEP latency without any other electrophysio-
logic abnormalities in 5% and myopathic motor units without
any other electrophysiologic abnormalities in 30%. These
findings differ from rheumatoid arthritis (RA) where polyneu-
ropathy in adults is mainly of axonal type and entrapment
neuropathies is the most common type of peripheral nerve
disorders, that commonly affect the median nerve (carpal
tunnel syndrome) [9,15,16].
In our study, no patient showed carpal tunnel syndrome.
This finding is supported by a previous study done for children
suffering from JIA, where it was found that, although wrist
involvement in JIA is similar to that seen in adults, median
nerves were electrophysiologically normal in JIA patients,
either with or without wrist involvement [15]. It was speculated
that increasing the carpal tunnel content due to the inflamma-
tory process may be tolerated by more elastic and growing
fibro-cartilaginous structures of the carpal tunnel in children
with arthritis. Another factor would be the difference between
the wrist deformities; being generally ulnar in JIA and being
radial in RA [15].
In our study, one patient with JIA developed subclinical
DPN entrapment under the inferior extensor retinaculum. This
patient had JIA of polyarticular type with arthritis of both
ankles and foot joints. A common site for DPN entrapment,
along the dorsum of the foot, occurs in the region of the first
and second tarsometatarsal joints as the medial branch of
the DPN traverses a narrow fibro-osseous tunnel between
the extensor hallucis brevis tendon and the deep fascia [17].
Entrapment occurs as the tendon crosses over the nerve. One
of the known causes of DPN entrapment is arthritis of the
talonavicular joint or at the first and second tarsometatarsal
joints or tendinitis or hypertrophic muscle belly of extensor
hallucis longus, extensor digitorum longus or tibialis anterior
[18,19].
Prolonged SEP latency (not associated with peripheral
neuropathy) was found in 4 patients, 2 of them had JIA and
the other 2 had JSLE. This can be explained by a focal or
generalized vasculopathy affecting the CNS [4].
The child with JSScl did not show any electrophysiological
abnormalities. This finding comes in agreement with previous
studies done for adults and children with SScl and they con-
cluded that SScl is thought to be the least likely of the collagen
vascular disorders to cause nervous system damage (peripheral
or central) [20–22], only children with the coup-de-sabre form
of localized scleroderma are at risk for CNS involvement [23].
The patient with overlap syndrome (JSScl and polymyosi-
tis) had objective neurologic abnormality. This is consistent
with a previous study which found that when polymyositis
occurs in children, it is often in the setting of overlap syndrome
with other CTDs [24]. This child had no electrophysiologic
abnormality on NCS but abnormalities were present on
EMG study in the form of abnormal resting activities, myo-
pathic motor units and early recruitment. This was revealed
by other studies for children and adults with polymyositiswhere peripheral nerve and CNS involvement was rare in
polymyositis and in dermatomyositis [25–27].
Myopathic motor unit action potentials were found in 9
patients (30%) (2 patients with JSLE and 7 patients with
JIA). All of them were receiving corticosteroids, so these
myopathic motor unit action potentials are mostly associated
with corticosteroids use [28,29]. Myositis is distinguished
from corticosteroid-related myopathy by demonstrating
electromyographic spontaneous activity which reflects the
ongoing disease activity [29,30].
A significant difference between patients and the control as
regards the distal motor latency of the ulnar, posterior tibial
and deep peroneal nerves and compound muscle action poten-
tial amplitude of ulnar nerve as well as motor conduction
velocity of posterior tibial and deep peroneal nerves was
observed. On the other hand, the sural nerve sensory conduc-
tion velocity and sensory nerve action potential amplitude
showed a significant difference when compared with the con-
trol. These results were in accordance with previous studies
done for adult patients with CTDs, which realized that the
most frequent manifestations of PNS vasculitis are asymmet-
ric, sensorimotor polyneuropathy [31–33]. Although any nerve
can be affected, most patients have initial symptoms in the
tibial or peroneal nerve [16,34]. Other studies found that
sensory nerves are more sensitive for pathological changes
than motor nerves and the sural nerve was the most frequent
and the first nerve to be affected [16,35].
In our study there was no relationship between electrophys-
iological abnormalities and the drugs used. This finding
suggests that neurological involvement is mostly related to
the disease itself not to drug complications and these
neurological changes can occur early in the disease course.
So, one must be alert to these changes early in the course of
the disease.
In this work we studied the clinical and subclinical neuro-
logical complications of common rheumatic disorders of child-
hood. As found by another study, the presence and the degree
of nervous system impairment varied widely, depending on the
diagnosis and course of the disorder [1]. Subclinical neurolog-
ical abnormalities were common findings, so PNS and CNS
evaluation is required for children with rheumatic CTDs,
especially those with JSLE, for early diagnosis and estimation
of peripheral and central neurological changes.
In conclusion, clinical neurological abnormalities are not
common in JCTDs whereas subclinical neurological abnormal-
ities affecting PNS, CNS and muscles are common findings.
Subclinical myopathy is a common finding in JCTDs and
mostly related to corticosteroid use. JSLE had the most com-
mon clinical (mononeuropathy) and subclinical neurologic
abnormalities. In JIA, subclinical PNS involvement is less
frequent and polyneuropathy is mostly demyelinating. A larger
scale longitudinal study is recommended in future research.Conflict of interest
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